Delivering 3 billion doses of Comirnaty in 2021.

Warne, Nicholas; Ruesch, Margaret; Siwik, Pamela; Mensah, Paul; Ludwig, John; Hripcsak, Michael; Godavarti, Ranga; Prigodich, Andrew; Dolsten, Mikael

Warne, Nicholas; Ruesch, Margaret; Siwik, Pamela; Mensah, Paul; Ludwig, John; Hripcsak, Michael; Godavarti, Ranga; Prigodich, Andrew; Dolsten, Mikael.

Warne N; Pfizer, New York, NY, USA.
Ruesch M; Pfizer, New York, NY, USA.
Siwik P; Pfizer, New York, NY, USA.
Mensah P; Pfizer, New York, NY, USA.
Ludwig J; Pfizer, New York, NY, USA.
Hripcsak M; Pfizer, New York, NY, USA.
Godavarti R; Pfizer, New York, NY, USA.
Prigodich A; Pfizer, New York, NY, USA.
Dolsten M; Pfizer, New York, NY, USA. mikael.dolsten@pfizer.com.

Nat Biotechnol ; 41(2): 183-188, 2023 02.

Article in English | MEDLINE | ID: covidwho-2236872

Subject(s)

BNT162 Vaccine; Vaccine Development

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccine Development / BNT162 Vaccine Topics: Vaccines Language: English Journal: Nat Biotechnol Journal subject: Biotechnology Year: 2023 Document Type: Article Affiliation country: S41587-022-01643-1

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google